###begin article-title 0
###xml 56 80 56 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 56 80 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Whi5 Regulation by Site Specific CDK-Phosphorylation in Saccharomyces cerevisiae
###end article-title 0
###begin p 1
Conceived and designed the experiments: MVW SFD. Performed the experiments: MVW MBS RAMdB. Analyzed the data: MVW MBS RAMdB HZ CW. Contributed reagents/materials/analysis tools: RAMdB HZ CW. Wrote the paper: MVW SFD.
###end p 1
###begin p 2
###xml 91 115 91 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 610 617 610 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 91 115 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
The Whi5 transcriptional repressor is a negative regulator of G1 cell cycle progression in Saccharomyces cerevisiae and is functionally equivalent to the Retinoblastoma (Rb) tumor suppressor protein in mammals. In early G1, Whi5 binds to and inhibits SBF (Swi4/Swi6) transcriptional complexes. At Start, Cln:Cdc28 kinases phosphorylate and inactivate Whi5, causing its dissociation from SBF promoters and nuclear export, allowing activation of SBF transcription and entry into late G1. In an analysis of Whi5 phosphorylation, we found that 10 of the 12 putative CDK phosphorylation sites on Whi5 were occupied in vivo in asynchronously growing cells. In addition, we identified 6 non-CDK Whi5 phosphorylation sites. Whi5 CDK and non-CDK phosphorylation mutants were functional and able to rescue the small cell size of whi5Delta cells. However, the Whi5 CDK mutant with all 12 putative CDK sites changed to alanine causes a dramatic cell cycle phenotype when expressed with a Swi6 CDK phosphorylation mutant. Mutational analysis of Whi5 determined that only four C-terminal CDK sites were necessary and sufficient for Whi5 inactivation when Swi6 CDK sites were also mutated. Although these four Whi5 CDK sites do not wholly determine Whi5 nuclear export, they do impact regulation of cell size. Taken together, these observations begin to dissect the regulatory role of specific phosphorylation sites on Whi5.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 359 362 359 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Breeden1">[1]</xref>
###xml 364 367 364 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Pardee1">[2]</xref>
###xml 492 495 492 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Johnston1">[3]</xref>
###xml 786 789 786 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Mendenhall1">[4]</xref>
###xml 973 976 973 976 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Spellman1">[5]</xref>
###xml 978 981 978 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Cho1">[6]</xref>
###xml 1185 1188 1185 1188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Breeden1">[1]</xref>
###xml 1326 1329 1326 1329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Wittenberg1">[7]</xref>
###xml 1488 1491 1488 1491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Koch1">[8]</xref>
###xml 308 313 <span type="species:ncbi:4932">yeast</span>
###xml 372 377 <span type="species:ncbi:4932">yeast</span>
###xml 860 865 <span type="species:ncbi:4932">yeast</span>
###xml 986 991 <span type="species:ncbi:4932">yeast</span>
Cell proliferation is a tightly regulated process where extracellular signals and intracellular checkpoints are integrated to control cell growth and division. When conditions for cell division are favorable, cells commit to enter the cell cycle during G1 phase at an irreversible transition termed Start in yeast and the Restriction Point in mammalian cells [1], [2]. In yeast, environmental nutrient availability regulates accumulation of cellular mass to a critical cell size before Start [3]. In mammalian cells, growth factor signaling determines passage through the Restriction Point that is also presumed to be partially responsive to cell size and mass. Failure to properly regulate cell cycle entry can result in abnormal division and lead to development of neoplastic disease [4]. The molecular events determining commitment to cell division in both yeast and mammalian cells involve regulated transcription of groups of genes required for cell cycle progression [5], [6]. In yeast, expression of genes at Start depends on SBF and MBF transcription factor complexes; each consists of the transcriptional coactivator Swi6 and a DNA binding protein, Swi4 or Mbp1, respectively [1]. In general, SBF controls transcription of cell cycle regulatory genes, while genes involved in DNA synthesis and repair are MBF targets [7]. Loss of both Swi4 and Mbp1 results in a permanent G1 arrest and cell lethality, demonstrating the essential function of these transcription factor complexes [8].
###end p 4
###begin p 5
###xml 150 153 150 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Costanzo1">[9]</xref>
###xml 155 159 155 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-deBruin1">[10]</xref>
###xml 300 304 300 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Dirick1">[11]</xref>
###xml 306 310 306 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Tyers1">[12]</xref>
###xml 326 330 326 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CLN3</italic>
###xml 436 440 436 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Dirick1">[11]</xref>
###xml 441 445 441 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Cross1">[13]</xref>
###xml 739 742 739 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Costanzo1">[9]</xref>
###xml 744 748 744 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-deBruin1">[10]</xref>
###xml 778 782 778 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WHI5</italic>
###xml 883 887 883 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Jorgensen1">[14]</xref>
###xml 1034 1038 1034 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Wijnen1">[15]</xref>
###xml 1155 1159 1155 1159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Wijnen1">[15]</xref>
###xml 1160 1164 1160 1164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Koch2">[17]</xref>
###xml 1398 1401 1398 1401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Costanzo1">[9]</xref>
###xml 1623 1627 1623 1627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Sidorova1">[16]</xref>
###xml 1629 1633 1629 1633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Geymonat1">[18]</xref>
###xml 1870 1874 1870 1874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-deBruin2">[19]</xref>
In early G1, SBF complexes bind target promoters, but due to binding by the Whi5 transcriptional repressor, do not initiate transcription until Start [9], [10]. The cyclin Cln3 is an activator of cell cycle progression and ensures proper timing of transcription once cells reach a critical cell size [11], [12]. Cells lacking CLN3 have a large cell size phenotype and are delayed in transcriptional activation and passage through Start [11]-[13]. Whi5 is a key target of Cln3-Cdc28 cyclin dependent kinase (CDK) in transcriptional activation of SBF. Phosphorylation of Whi5 and SBF complexes by Cln3-Cdc28 results in Whi5 dissociation from SBF promoters and nuclear export, allowing for induction of SBF transcription and cell cycle entry [9], [10]. Consequently, cells lacking WHI5 initiate SBF transcription prematurely, driving cells past Start and resulting in a small cell size [14]. In addition to Whi5, Swi4 and Swi6 are also known targets of CDK phosphorylation and genetic studies implicate Swi6 as a critical target of Cln3 [15]. However, mutation of CDK phosphorylation sites of Swi4 or Swi6 does not interfere with timing of SBF transcription [15]-[17]. Interestingly, a Whi5 CDK phosphorylation mutant causes cell lethality when expressed in a Swi6 CDK phosphorylation mutant background, suggesting that CDK phosphorylation of Whi5 and Swi6 is redundant for transcriptional activation [9]. Swi6 is also subject to inhibitory phosphorylation. During the late G1 to early S-phase transition, Swi6 is phosphorylated by cyclin Clb6-Cdc28 on Ser-160, changing Swi6 cellular localization from nuclear to cytoplasmic [16], [18]. This serves to inactivate SBF transcription outside of G1. It is not currently known what mechanisms repress MBF in early G1 or activate MBF at Start, although the MBF target Nrm1 is responsible for repression of MBF upon exit from G1 [19].
###end p 5
###begin p 6
###xml 240 244 240 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Sun1">[20]</xref>
###xml 371 375 371 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Harbour1">[21]</xref>
###xml 377 381 377 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Kaelin1">[22]</xref>
###xml 560 564 560 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Ho1">[23]</xref>
###xml 706 710 706 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Ezhevsky1">[24]</xref>
###xml 822 826 822 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Knudsen1">[25]</xref>
###xml 828 832 828 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Kitagawa1">[26]</xref>
###xml 958 962 958 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Brown1">[27]</xref>
###xml 964 968 964 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Ezhevsky2">[28]</xref>
A functionally similar system of transcriptional regulation occurs in mammalian cells. The E2F family of transcription factors control expression of a suite of E2F target genes essential for late G1 cell cycle progression and DNA synthesis [20]. In early G1, E2Fs are bound and repressed by the Retinoblastoma Tumor Suppressor protein (Rb), a functional analogue of Whi5 [21], [22]. At the restriction point, activation of Cyclin E-Cdk2 kinase complexes results in Rb hyper-phosphorylation and inactivation, allowing for cell cycle-dependent E2F transcription [23]. Studies of Rb regulation by phosphorylation show Rb is phosphorylated at low levels, or hypo-phosphorylated, when bound to E2Fs in early G1 [24]. Additionally, it has been proposed by some groups that specific CDK sites on Rb are utilized for inactivation [25], [26], while others suggest a model where a critical threshold of phosphorylation on any of Rb's 16 CDK sites induces inactivation [27], [28]. However, the mechanistic understanding of Rb regulation by phosphorylation remains unclear.
###end p 6
###begin p 7
###xml 78 83 <span type="species:ncbi:4932">yeast</span>
###xml 163 168 <span type="species:ncbi:4932">yeast</span>
Due to the conserved regulatory pathways controlling G1 transcription between yeast and mammalian cells, investigation of regulation by phosphorylation of Whi5 in yeast could provide insight into mammalian G1 cell cycle and Rb regulation. In an analysis of Whi5 phosphorylation, we determined that Whi5 is also found hypo-phosphorylated in early G1, but that hypo-phosphorylation is not required for Whi5 function. Additionally, we identify four specific CDK sites in Whi5 that are critical for Whi5 inactivation and the regulation of cell size when Swi6 phosphorylation is also prevented. These results demonstrate that regulation of Whi5 by phosphorylation relies on specific CDK sites.
###end p 7
###begin title 8
Materials and Methods
###end title 8
###begin title 9
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast Culture and Strains
###end title 9
###begin p 10
###xml 264 268 264 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WHI5</italic>
###xml 304 308 304 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Longtine1">[29]</xref>
###xml 314 318 314 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WHI5</italic>
###xml 376 380 376 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WHI5</italic>
###xml 469 473 469 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Brachmann1">[30]</xref>
###xml 46 51 <span type="species:ncbi:4932">yeast</span>
Cells were grown in standard media containing yeast extract, peptone, and 2% glucose. For induction experiments, cells were grown overnight in media containing 2% raffinose then inoculated into 2% galactose media or galactose plates. A 13x-Myc tag was appended to WHI5 using the method of Longtine et al [29]. The WHI5 promoter construct derived from 545 base pairs 5' of the WHI5 open reading frame was PCR amplified from genomic DNA and cloned into the pRS413 vector [30].
###end p 10
###begin p 11
###xml 4 11 4 11 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004300-t001">Table 1</xref>
###xml 26 31 <span type="species:ncbi:4932">yeast</span>
See Table 1 for a list of yeast strains used in this study.
###end p 11
###begin title 12
Protein Purification
###end title 12
###begin p 13
###xml 17 31 17 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAL1-WHI5-3xHA</italic>
###xml 35 55 35 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAL1-WHI5-12Ala-3xHA</italic>
Cells expressing GAL1-WHI5-3xHA or GAL1-WHI5-12Ala-3xHA were grown in raffinose then induced with galactose for ten hours. Cells from twelve liters of culture were harvested by centrifugation and drop frozen in liquid nitrogen. Cells were broken with a Waring blender in liquid nitrogen. Resulting powder was resuspended in RIPA buffer with protease and phosphatase inhibitors. Cells debris was pelleted by high-speed centrifugation. Immunoprecipitation with HA affinity resin (Roche) was performed overnight. Immunoprecipitates were washed and boiled in SDS-sample buffer then resuspended in RIPA buffer, diluting the SDS to 1%, before a second immunoprecipitation was performed. Samples from the double immunoprecipitation were separated by 10% SDS-PAGE and stained with Coomassie blue.
###end p 13
###begin title 14
Mass Spectrometry
###end title 14
###begin p 15
###xml 86 90 86 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Smolka1">[31]</xref>
###xml 228 232 224 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Smolka1">[31]</xref>
###xml 426 431 <span type="species:ncbi:4932">yeast</span>
After in-gel digestion, phosphopeptides were purified by IMAC as previously described [31]. Purified phosphopeptides were analyzed by microLC-ESI-MS/MS on a Thermo Finnigan LTQ quadrupole ion trap mass spectrometer as described [31]. For data analysis, SEQUEST (version 3.4 beta 2) program running on a Sorcerer system (SageN, San Jose, CA) was used for peptide identification. Database search was performed using the budding yeast database. The following variable modifications were considered: +80 Da (phosphorylation) for serine, threonine and tyrosine residues; +16 Da (oxidation) for methionine residues. Up to 4 variable modifications were allowed per peptide and peptide mass tolerance used was 3 Da. A semi-tryptic restriction was applied, and only the top-matched peptides with a probability score above 0.9 were subsequently considered for close inspection. Each MS/MS spectrum that led to phosphopeptide identification was manually verified to confirm all significant ions were accounted for, and then validated.
###end p 15
###begin title 16
Protein Analysis and Phosphatase Treatment
###end title 16
###begin p 17
###xml 619 623 619 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Flick1">[32]</xref>
Cells were broken with glass beads in 50 mM Tris, pH 8, 150 mM NaCl, 2 mM EDTA, 10% glycerol, 0.2% NP-40 lysis buffer containing protease (PMSF, aprotinin, leupeptin, benzamidine) and phosphatase inhibitors (Sigma cocktails 1 and 2). Immunoprecipitation was performed with anti-Myc antibody (Santa Cruz) and protein G beads (Zymed) or anti-HA conjugated beads (Roche). After washing with lysis buffer without phosphatase inhibitors, and 50 mM Tris, pH 8, 50 mg/mL BSA, 25 uM DTT buffer, immunoprecipitates were incubated with lambda protein phosphatase (New England Biolabs) in supplied buffer for 1 hour at 30 degrees [32]. Analysis of protein migration utilized 10% SDS-PAGE run for 10-12 cm.
###end p 17
###begin title 18
Cell Size Measurements
###end title 18
###begin p 19
Cell size analysis was performed on asynchronous cultures during log-phase growth using a Coulter Z2 Particle Cell Analyzer (Beckman-Coulter). Cultures were briefly sonicated before analysis. Cell size distribution was analyzed with the Z2 AccuComp software (Beckman-Coulter).
###end p 19
###begin title 20
Microscopy
###end title 20
###begin p 21
Fluorescence and differential interference contrast microscopy was performed on live cells with a DeltaVision RT Microscope (Applied Precision Life Science) using a 100x oil objective. Image processing was done with ImageJ software and fluorescent and DIC images were overlaid using Adobe Photoshop.
###end p 21
###begin title 22
Cell Synchronization
###end title 22
###begin p 23
Cells in log phase growth were washed, resuspended in fresh media containing 5 microg/mL alpha factor (Sigma), and incubated for three hours at 30 degrees. To release, cells were washed twice with cold media then inoculated into warm media. At indicated time points, samples were taken, cooled with ice, sonicated, then analyzed for budding index.
###end p 23
###begin title 24
Results
###end title 24
###begin title 25
###xml 51 58 51 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Whi5 is phosphorylated on 16 CDK and non-CDK sites in vivo
###end title 25
###begin p 26
###xml 168 171 168 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Costanzo1">[9]</xref>
###xml 173 177 173 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-deBruin1">[10]</xref>
###xml 275 282 275 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 313 317 313 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-deBruin1">[10]</xref>
###xml 358 365 358 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 516 520 516 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAL1</italic>
###xml 857 863 857 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004300-g001">Fig. 1</xref>
###xml 1002 1006 1002 1006 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-deBruin1">[10]</xref>
###xml 1307 1313 1307 1313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004300-g001">Fig. 1</xref>
Whi5 contains 12 putative CDK phosphorylation sites typified by S/T-P(-X-B) and phosphorylation by Cln:Cdk activity has been shown to be important in Whi5 inactivation [9], [10]. de Bruin et al. had previously determined that CDK sites 2, 4, 5, 10 and 12 were phosphorylated in vivo from samples of late G1 cells [10]. To identify Whi5 phosphorylation sites in vivo in a comprehensive manner, we performed mass spectrometry analysis of Whi5. Wild type Whi5 containing a 3x HA C-terminal tag under the control of the GAL1 promoter was immunopurified from asynchronously growing cells, digested with trypsin, and phosphopeptides were purified by IMAC resin liquid chromatography enrichment then analyzed by mass spectrometry. Ten of the 12 putative Whi5 CDK phosphorylation sites, numbered 3-12, were identified as being phosphorylated in asynchronous cells (Fig. 1), while phosphorylation of sites 1 and 2 were not detected by our methods. Because de Bruin et al. verified phosphorylation of CDK site 2 [10], and it is possible CDK site 1 is phosphorylated but not detected by our methods, we utilize a Whi5-12Ala phosphorylation mutant in our following studies. Surprisingly, in addition to CDK sites, we also identified 6 other non-CDK serine and threonine residues phosphorylated on Whi5, labeled A to F (Fig. 1). We note that 5 of the 6 non-CDK phosphorylation sites contain an acidic residue distal to the phosphorylated S/T. Mass spectrometry analysis of 3x HA C-terminal tagged mutant Whi5 with all 12 CDK sites changed to alanine (Whi5-12Ala-3xHA) maintained phosphorylation of these 6 non-CDK sites. In total, we identified 16 phosphorylation sites on Whi5 in asynchronously growing cells.
###end p 26
###begin title 27
Whi5 is phosphorylated on 16 sites in vivo.
###end title 27
###begin p 28
The primary amino acid sequence of Whi5 with putative CDK sites boxed in blue. Arrows indicate amino acids found phosphorylated in vivo. Non-CDK sites phosphorylated in vivo are boxed in green.
###end p 28
###begin title 29
Whi5 is phosphorylated at all stages of the cell cycle
###end title 29
###begin p 30
###xml 140 144 140 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WHI5</italic>
###xml 241 248 241 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004300-g002">Fig. 2A</xref>
###xml 351 355 351 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Jeoung1">[33]</xref>
###xml 357 361 357 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Tyers2">[34]</xref>
###xml 710 717 710 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004300-g002">Fig. 2B</xref>
We next analyzed the cell cycle dependency of Whi5 phosphorylation, utilizing a strain containing a C-terminal 3x-Myc tag integrated at the WHI5 locus. In lysates from asynchronously growing cells, Whi5-13xMyc protein migrates as a doublet (Fig. 2A). However, in cells arrested in G1 phase by mating pheromone, where CDK activity is inhibited by Far1 [33], [34], Whi5-13xMyc migrates as a single, faster migrating band. In contrast, in cells arrested in M phase by nocodazole, where CDK activity is high, the slower migrating species was enriched. To test whether the difference in migration of the Whi5 bands was due to phosphorylation, immunoprecipitates of Whi5-13xMyc were treated with lambda phosphatase (Fig. 2B). Upon phosphatase treatment, both the slower and faster migrating species of Whi5 from asynchronous cells collapsed into a third, fastest migrating un-phosphorylated band. Phosphatase treatment of Whi5-13xMyc from mating pheromone and nocodazole-arrested cells both induced appearance of the un-phosphorylated band. Thus, Whi5 can be separated into three species: the slowest migrating form of Whi5, designated hyper-phosphorylated; the middle form, designated hypo-phosphorylated; and the fastest form, designated un-phosphorylated. We note that the un-phosphorylated form of Whi5 was not found at any cell cycle stage or even in mating pheromone arrested cells. In addition, we observe that Whi5 from mating pheromone arrested cells with inhibited CDK activity shifted downward after phosphatase treatment, suggesting the presence of non-CDK phosphorylation events.
###end p 30
###begin title 31
Whi5 is phosphorylated throughout the cell cycle.
###end title 31
###begin p 32
###xml 545 549 545 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAL1</italic>
(A) Cultures of strains expressing Whi5-13xMyc from the endogenous locus were arrested in G1 phase with alpha factor or in metaphase with nocodazole. Western blot of Whi5-13xMyc shows two different migrating forms, indicated by arrows. (B) Western blot of immunopurified Whi5-13xMyc treated with or without lambda phosphatase. Three different migrating forms indicated by arrows represent unphosphorylated, hypo-phosphorylated, and hyper-phosphorylated Whi5. (C) Strains carrying CEN plasmids of phosphorylation mutants of Whi5-13xMyc under the GAL1 promoter were grown in galatcose before immunopurification. Whi5-WT, non CDK mutant 6Ala, CDK mutant 12Ala, and CDK/non-CDK mutant 18Ala were treated with phosphatase as in B. Arrows indicate migration of three different phosphorylation forms.
###end p 32
###begin p 33
###xml 367 374 367 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004300-g002">Fig. 2C</xref>
###xml 696 706 696 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vice versa</italic>
###xml 858 865 858 865 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
The phosphorylation status of Whi5 mutants was also analyzed by phosphatase treatment. Wild type Whi5 or phosphorylation mutants containing a C-terminal 13xMyc tag were expressed from the GAL1 promoter on CEN plasmids. In samples of asynchronous cells, mutation of the 6 non-CDK sites (A-F) to alanine did not effect the migration of Whi5 compared to wild type Whi5 (Fig. 2C). Consistent with the mass spec analysis, mutation of Whi5 CDK sites 1-12 to alanine resulted in a single hypo-phosphorylated band that increased mobility after phosphatase treatment. Since both Whi5-6Ala and Whi5-12Ala were found phosphorylated, the non-CDK sites A-F are not essential for CDK site phosphorylation, and vice versa. Finally, when all 12 CDK and 6 non-CDK sites were mutated to alanine in Whi5-18Ala, migration did not change upon phosphatase treatment. In addition, in vivo orthophosphate labeling verified that both Whi5-6A and Whi5-12Ala are phosphorylated, although to a lesser extent than wild type Whi5, while phosphorylation of Whi5-18Ala was negligible (data not shown).
###end p 33
###begin title 34
Functional Analysis of Whi5 phosphorylation mutants
###end title 34
###begin p 35
###xml 0 9 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">whi5&#916;</italic>
###xml 52 56 48 52 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Jorgensen1">[14]</xref>
###xml 158 167 154 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">whi5&#916;</italic>
###xml 180 187 172 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004300-g003">Fig. 3A</xref>
###xml 290 299 282 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">whi5&#916;</italic>
###xml 364 368 352 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WHI5</italic>
###xml 417 426 405 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">whi5&#916;</italic>
###xml 539 549 523 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WHI5-12Ala</italic>
###xml 655 665 639 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WHI5-12Ala</italic>
###xml 730 737 714 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WHI5-WT</italic>
###xml 1005 1014 989 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">whi5&#916;</italic>
###xml 1148 1157 1128 1133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">whi5&#916;</italic>
###xml 1192 1196 1168 1172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WHI5</italic>
###xml 1208 1218 1184 1194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WHI5-12Ala</italic>
###xml 1226 1235 1202 1211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WHI5-6Ala</italic>
###xml 1250 1260 1226 1236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WHI5-18Ala</italic>
###xml 1298 1302 1274 1278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MET3</italic>
###xml 1370 1379 1346 1351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">whi5&#916;</italic>
###xml 1457 1464 1429 1436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004300-g003">Fig. 3B</xref>
###xml 1577 1581 1549 1553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MET3</italic>
###xml 1632 1636 1604 1608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-deBruin1">[10]</xref>
###xml 1861 1870 1833 1838 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cln3&#916;</italic>
###xml 1937 1940 1905 1908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Costanzo1">[9]</xref>
###xml 2057 2061 2025 2029 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAL1</italic>
###xml 2107 2116 2075 2080 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cln3&#916;</italic>
###xml 2124 2131 2088 2095 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004300-g003">Fig. 3C</xref>
whi5Delta cells exhibit a small cell size phenotype [14]. To assess the functionality of Whi5 phosphorylation mutants, we assayed for their ability to rescue whi5Delta small size (Fig. 3A). Wild type parent strain BY4741 had a mean cell size distribution of 48.2 fL, while the mean size of whi5Delta cells was 36.2 fL in this experiment. Introduction of wild type WHI5 on a CEN plasmid under its native promoter into whi5Delta cells rescues the small cell size defect and returned the culture to a mean cell size of 53.2 fL. Expression of WHI5-12Ala also rescued the small cell size phenotype, with a mean cell size of 53.3 fL. Importantly, expression of WHI5-12Ala from its own promoter did not result in a larger cell size than WHI5-WT. This suggests CDK phosphorylation of Whi5 is not essential for SBF activation or timing of Start, as loss of Whi5 CDK phosphorylation does not delay cell cycle progression. Mutants in the non-CDK phosphorylation sites of Whi5 were also assayed for ability to rescue whi5Delta cell size. In this experiment, where cells are grown in synthetic media, parent strain BY4741 had a mean cell size of 35.3 fL, while whi5Delta cells were 31.5 fL. Expression of WHI5 wild type, WHI5-12Ala (CDK), WHI5-6Ala (non-CDK), or WHI5-18Ala (CDK and non-CDK) from the inducible MET3 promoter on CEN plasmids was able to rescue the small cell size of whi5Delta mutants, with mean cell sizes of 42.1, 43.5, 43.2 and 42.4 fL, respectively (Fig. 3B). We note that the slightly larger cell size observed is likely due to constitutive expression of Whi5 from the MET3 promoter, and was also observed by de Bruin et al [10]. These observations indicate that in wild type cells, phosphorylation of Whi5 on CDK sites or non-CDK sites is not essential for regulation of cell size. In addition, it has previously been shown that Whi5 overexpression in cln3Delta cells results in permanent cell cycle arrest in G1 prior to Start [9]. Similar to wild type Whi5, overexpression of Whi5-12Ala, Whi5-6Ala, or Whi5-18Ala phosphorylation mutants from the GAL1 promoter on CEN plasmids caused lethality of cln3Delta cells (Fig. 3C), suggesting that hypo-phosphorylation of either CDK or non-CDK sites is not required for Whi5 to antagonize Cln3 activity.
###end p 35
###begin title 36
Whi5 hypo-phosphorylation is not necessary for function.
###end title 36
###begin p 37
###xml 21 30 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">whi5&#916;</italic>
###xml 110 114 106 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WHI5</italic>
###xml 176 180 172 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WHI5</italic>
###xml 222 231 218 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">whi5&#916;</italic>
###xml 357 361 349 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MET3</italic>
###xml 412 421 404 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cln3&#916;</italic>
###xml 542 546 530 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAL1</italic>
###xml 664 684 652 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">swi6&#916; [SWI6-SA4]</italic>
###xml 804 808 788 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAL1</italic>
(A) Size analysis of whi5Delta cells with CEN plasmids expressing Whi5-WT or Whi5-12Ala (CDK mutant) from the WHI5 promoter, a 545 bp fragment from sequence directly 5' of the WHI5 open reading frame. (B) Size analysis of whi5Delta cells expressing Whi5-WT, Whi5-12Ala (CDK mutant), Whi5-6Ala (non CDK mutant), or Whi5-18A (CDK and non-CDK mutant) from the MET3 promoter on a CEN plasmid. (C) Wild type cells or cln3Delta cells with empty vector or CEN plasmid constructs of Whi5-WT, Whi5-12Ala, Whi5-6Ala, or Whi5-18Ala under control of the GAL1 promoter. Cells were spotted in serial five fold dilutions on glucose or galactose media and incubated 48 hours. (D) swi6Delta [SWI6-SA4] cells bearing either empty vector or CEN plasmid constructs of Whi5-WT, Whi5-12Ala, Whi5-6Ala, or Whi5-18Ala under the GAL1 promoter. Cells were spotted in serial five fold dilutions on glucose or galactose media and incubated 48 hours.
###end p 37
###begin title 38
Specific CDK phosphorylation sites of Whi5 are required for function
###end title 38
###begin p 39
###xml 110 113 110 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Costanzo1">[9]</xref>
###xml 115 119 115 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-deBruin1">[10]</xref>
###xml 257 260 257 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Costanzo1">[9]</xref>
###xml 683 687 683 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WHI5</italic>
###xml 700 707 700 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WHI5-WT</italic>
###xml 709 719 709 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WHI5-12Ala</italic>
###xml 721 730 721 730 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WHI5-6Ala</italic>
###xml 735 745 735 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WHI5-18Ala</italic>
###xml 765 769 765 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAL1</italic>
###xml 901 909 901 909 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SWI6-SA4</italic>
###xml 911 921 911 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WHI5-12Ala</italic>
###xml 926 936 926 936 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WHI5-18Ala</italic>
###xml 983 990 983 990 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WHI5-WT</italic>
###xml 994 1003 994 1003 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WHI5-6Ala</italic>
###xml 1017 1024 1017 1024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004300-g003">Fig. 3D</xref>
###xml 1112 1116 1112 1116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SWI6</italic>
###xml 1120 1128 1120 1128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SWI6-SA4</italic>
Expression of various Whi5 phosphorylation mutants in wild type cells does not result in a dramatic phenotype [9], [10]. However, overexpression of Whi5-12Ala in cells that harbor the Swi6-SA4 mutant lacking four CDK sites results in a severe growth defect [9], suggesting that phosphorylation of either Whi5 or Swi6 is required for SBF activation and cell cycle promotion. To test if the non-CDK sites of Whi5 are similarly essential for SBF activation in the presence of Swi6-SA4, Whi5 mutants containing alanine substitutions for the 6 non-CDK sites (Whi5-6Ala), and all CDK and non-CDK sites (Whi5-18Ala) were tested in this assay. In cells expressing wild type Swi6, all of the WHI5 constructs, WHI5-WT, WHI5-12Ala, WHI5-6Ala, or WHI5-18Ala expressed from the GAL1 promoter on CEN plasmids, showed no change in growth rate as detected in this assay (data not shown). However, in combination with SWI6-SA4, WHI5-12Ala and WHI5-18Ala cells were inviable, whereas cells expressing WHI5-WT or WHI5-6Ala were viable (Fig. 3D). Thus, phosphorylation of Whi5 non-CDK sites is not necessary for SBF activation in a SWI6 or SWI6-SA4 genetic background. We are currently unable to ascribe a biological function for phosphorylation of Whi5 at the 6 non-CDK sites.
###end p 39
###begin p 40
###xml 65 72 65 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 74 80 74 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004300-g001">Fig. 1</xref>
###xml 102 106 102 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-deBruin1">[10]</xref>
###xml 407 415 407 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SWI6-SA4</italic>
###xml 424 430 424 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004300-g004">Fig. 4</xref>
###xml 466 469 466 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Costanzo1">[9]</xref>
###xml 607 617 607 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WHI5-12Ala</italic>
###xml 633 642 633 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WHI5-7Ala</italic>
###xml 700 704 700 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-deBruin1">[10]</xref>
###xml 742 750 742 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SWI6-SA4</italic>
###xml 752 771 752 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004300-g004">Fig. 4, lines 2 &amp; 3</xref>
###xml 1045 1054 1045 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WHI5-4Ala</italic>
###xml 1129 1137 1129 1137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SWI6-SA4</italic>
###xml 1160 1174 1160 1174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004300-g004">Fig. 4, line 4</xref>
###xml 1204 1205 1204 1205 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 1195 1205 1195 1205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WHI5-8Ala<sup>1</sup></italic>
###xml 1285 1293 1285 1293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SWI6-SA4</italic>
###xml 1314 1328 1314 1328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004300-g004">Fig. 4, line 5</xref>
###xml 1760 1761 1760 1761 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1751 1761 1751 1761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WHI5-8Ala<sup>2</sup></italic>
###xml 1763 1777 1763 1777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004300-g004">Fig. 4, line 6</xref>
###xml 1784 1792 1784 1792 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SWI6-SA4</italic>
Although phosphorylation of multiple Whi5 CDK sites was detected in vivo (Fig. 1 and de Bruin et al.) [10], it is not known whether specific CDK sites or a threshold amount of phosphorylation determines Whi5 inactivation and dissociation from SBF. To test these two competing hypotheses of Whi5 inactivation, we performed a mutational analysis of Whi5 CDK sites and assayed for genetic interaction with the SWI6-SA4 allele (Fig. 4). Consistent with previous reports [9], none of the Whi5 CDK mutants assayed caused growth defects when induced in cells expressing wild type Swi6 (data not shown). Similar to WHI5-12Ala, expression of WHI5-7Ala (CDK sites 2, 3, 5, 8, 9, 10, and 12 mutated to alanine) [10] caused lethality in combination with SWI6-SA4 (Fig. 4, lines 2 & 3). Based on a preliminary survey of phosphorylation site mutants, we initially focused our attention on the C-terminal CDK phosphorylation sites. Four C-terminal CDK sites of Whi5 (8, 9, 10, and 12) as a group were necessary and sufficient for viability with Swi6-SA4. When WHI5-4Ala, with the four sites mutated to alanine, is expressed in combination with SWI6-SA4, cells were inviable (Fig. 4, line 4). In contrast, when WHI5-8Ala1, where the other 8 CDK sites in Whi5 are mutated to alanine, is expressed with SWI6-SA4, cells were viable (Fig. 4, line 5). This demonstrates that CDK sites 8, 9, 10, and 12 are specifically required for Whi5 inactivation in this assay. To rule out the possibility that phosphorylation of any four CDK sites was sufficient to inactivate Whi5, several constructs having four or more wild type CDK sites were also analyzed. For example, when four N-terminal CDK sites (2, 3, 4, and 5) are wild type while the other eight CDK sites are alanine in WHI5-8Ala2 (Fig. 4, line 6), the SWI6-SA4 cells were still inviable, suggesting that the four N-terminal sites were not sufficient to allow for viability.
###end p 40
###begin title 41
Mutational analysis of Whi5 phosphorylation sites.
###end title 41
###begin p 42
###xml 4 24 4 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">swi6&#916; [SWI6-SA4]</italic>
###xml 91 95 87 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAL1</italic>
(A) swi6Delta [SWI6-SA4] cells expressing Whi5-WT or Whi5 phosphorylation mutants from the GAL1 promoter. Cells were spotted in serial 5 fold dilutions on galactose media and incubated 48 hours. The table indicates the CDK sites of Whi5 that were left wild type (S/T) or mutated to alanine (A) for each mutant construct. (B) Schematic of the Whi5 protein showing relative location of CDK sites, numbered 1-12.
###end p 42
###begin p 43
###xml 304 322 304 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004300-g004">Fig. 4, lines 7&#8211;10</xref>
###xml 596 615 596 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004300-g004">Fig. 4, lines 11&#8211;14</xref>
###xml 860 875 860 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004300-g004">Fig. 4, line 15</xref>
###xml 1251 1287 1251 1287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004300-g004">Fig. 4, lines 17 &amp; 18, lines 19 &amp; 20</xref>
Additional analysis of CDK sites 8, 9, 10, and 12 was performed to assess their function as single sites, pairs of sites, or in groups of three. Mutation of site 10 or 12 alone, or pairs of sites (10 and 12; or 8 and 9) to alanine, while leaving the other CDK sites wild type did not affect cell growth (Fig. 4, lines 7-10). This demonstrates that no single C-terminal CDK site or pair of sites is necessary for viability. Conversely, mutating all other CDK sites to alanine, leaving only single CDK sites 10 or 12, or pairs of sites (10 and 12; or 8 and 9) wild type did not permit cell growth (Fig. 4, lines 11-14). This indicates that phosphorylation of a single site or pair of sites is not sufficient to support cell viability. Interestingly, when three CDK sites (8, 9, and 12; or 8, 9, and 10) were left wild type, they were sufficient to allow growth (Fig. 4, line 15), indicating 3 out of the 4 C-terminal CDK sites are sufficient for viability. Because these mutants with only three functional CDK sites are viable, the specific C-terminal CDK sites are adequate to promote Whi5 inactivation. However, Whi5 regulation by phosphorylation is complex in that some combinations of C-terminal mutations with other CDK sites influenced viability (Fig. 4, lines 17 & 18, lines 19 & 20). While CDK sites 8, 9, 10, and 12 are both necessary and sufficient for viability in combination with Swi6-SA4, supporting a model of specific sites utilized for inactivation, other CDK sites are able to support inactivation in certain combinations.
###end p 43
###begin title 44
Localization of Whi5 CDK mutants
###end title 44
###begin p 45
###xml 115 118 115 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Costanzo1">[9]</xref>
###xml 178 182 178 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Sidorova1">[16]</xref>
###xml 389 392 389 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Costanzo1">[9]</xref>
###xml 503 510 503 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004300-g005">Fig. 5A</xref>
###xml 601 608 601 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004300-g005">Fig. 5B</xref>
###xml 670 673 670 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Costanzo1">[9]</xref>
###xml 792 799 792 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004300-g005">Fig. 5C</xref>
###xml 860 862 860 862 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nd</sup>
###xml 850 868 850 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004300-g005">Fig. 5C, 2<sup>nd</sup> panel</xref>
###xml 873 880 873 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004300-g005">Fig. 5E</xref>
###xml 892 893 892 893 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 1012 1026 1012 1026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004300-g005">Fig. 5D and 5E</xref>
###xml 1098 1106 1098 1106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SWI6-SA4</italic>
###xml 1183 1190 1183 1190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004300-g005">Fig. 5E</xref>
###xml 1241 1249 1241 1249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SWI6-SA4</italic>
In wild type cells, Whi5 localization is nuclear in early G1, then exported to the cytoplasm just prior to budding [9]. Since Swi6-SA4 is constitutively localized in the nucleus [16], we hypothesized that Whi5 CDK mutants that caused lethality with Swi6-SA4 might also have defects in nuclear export. Localization of GFP tagged Whi5 was examined in wild type cells. As previously reported [9], Whi5-WT-GFP is nuclear in unbudded cells and cells just exiting mitosis, but is cytoplasmic in budded cells (Fig. 5A). However, Whi5-12Ala-GFP was localized to the nucleus in both unbudded and budded cells (Fig. 5B), confirming that CDK phosphorylation is required for export [9]. The localization of Whi5-4Ala-GFP, containing mutations of CDK sites 8, 9, 10, and 12, is nuclear in unbudded cells (Fig. 5C), but is cytoplasmic in only 16% of budded cells (Fig. 5C, 2nd panel and Fig. 5E). Whi5-8Ala1-GFP, with CDK sites 8, 9, 10, and 12 wild type, is nuclear in unbudded cells, and is cytoplasmic 35% of budded cells (Fig. 5D and 5E). The localization of Whi5-WT-GFP and CDK mutants was also examined in SWI6-SA4 cells, but was not different than localization observed in wild type cells (Fig. 5E). These observations suggest that in wild type or SWI6-SA4 cells, Whi5 C-terminal CDK sites 8, 9, 10, and 12 influence localization, but are not entirely necessary or sufficient for wild type localization.
###end p 45
###begin title 46
Cellular localization of Whi5 phosphorylation mutants.
###end title 46
###begin p 47
###xml 24 40 24 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAL1-WHI5-WT-GFP</italic>
###xml 46 65 46 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAL1-WHI5-12Ala-GFP</italic>
###xml 71 89 71 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAL1-WHI5-4Ala-GFP</italic>
###xml 98 116 98 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAL1-WHI5-8Ala-GFP</italic>
###xml 408 428 408 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">swi6&#916; [SWI6-SA4]</italic>
(A) Cultures containing GAL1-WHI5-WT-GFP, (B) GAL1-WHI5-12Ala-GFP, (C) GAL1-WHI5-4Ala-GFP, or (D) GAL1-WHI5-8Ala-GFP on a CEN plasmid were grown in galactose media and photographed for Whi5-GFP fluorescence in unbudded and budded cells. Representative cells are shown. (E) Graph of Whi5 localization in budded cells, showing the percentage of budded cells with cytoplasmic Whi5 in either wild type BY4741 or swi6Delta [SWI6-SA4] cells.
###end p 47
###begin title 48
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MSN5</italic>
MSN5 is required for Whi5 nuclear export
###end title 48
###begin p 49
###xml 57 61 57 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Queralt1">[35]</xref>
###xml 94 97 94 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Costanzo1">[9]</xref>
###xml 99 103 99 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-deBruin1">[10]</xref>
###xml 173 182 173 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">msn5&#916;</italic>
###xml 259 266 255 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004300-g006">Fig. 6A</xref>
###xml 297 306 293 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">swi6&#916;</italic>
###xml 314 321 306 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004300-g006">Fig. 6B</xref>
###xml 415 419 407 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAL1</italic>
###xml 548 555 540 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004300-g006">Fig. 6C</xref>
###xml 572 581 564 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAL1-MSN5</italic>
###xml 674 681 666 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004300-g006">Fig. 6C</xref>
###xml 695 704 687 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAL1-MSN5</italic>
###xml 747 769 739 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAL1-WHI5-12A SWI6-SA4</italic>
###xml 856 860 848 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Queralt1">[35]</xref>
###xml 861 865 853 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Kaffman1">[38]</xref>
###xml 906 915 898 903 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">msn5&#916;</italic>
###xml 920 929 908 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">swi6&#916;</italic>
###xml 937 944 921 928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004300-g006">Fig. 6D</xref>
###xml 1072 1081 1056 1061 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">msn5&#916;</italic>
###xml 1086 1095 1066 1071 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">swi6&#916;</italic>
Swi6 nuclear export is dependent on the karyopherin Msn5 [35]. Because Swi6 and Whi5 interact [9], [10], we examined whether Whi5 nuclear export was also Msn5 dependent. In msn5Delta cells, GFP tagged Whi5-WT was constitutively nuclear, even in budded cells (Fig. 6A). Whi5-WT was also nuclear in swi6Delta cells (Fig. 6B), suggesting that Swi6 is also involved in Whi5 nuclear export. Msn5 overexpression from the GAL1 promoter was not sufficient to induce ectopic nuclear export of Whi5-WT, as its localization remains nuclear in unbudded cells (Fig. 6C). Additionally, GAL1-MSN5 was unable to induce export of Whi5-12Ala and localization remained constitutively nuclear (Fig. 6C). Similarly, GAL1-MSN5 was unable to rescue the growth defect of GAL1-WHI5-12A SWI6-SA4 co-expressing cells (data not shown). Because Msn5 is known to export phosphoproteins [35]-[38], we examined phosphorylation of Whi5 in msn5Delta and swi6Delta cells (Fig. 6D). Immunoprecipitation and phosphatase treatment revealed that Whi5-WT was both hypo-phosphorylated and hyper-phosphorylated in msn5Delta and swi6Delta cells similar to wild type cells, indicating that the failure to export is not due to lack of Whi5 CDK phosphorylation.
###end p 49
###begin title 50
MSN5 is required for Whi5 nuclear export.
###end title 50
###begin p 51
###xml 4 13 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">msn5&#916;</italic>
###xml 28 37 24 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">swi6&#916;</italic>
###xml 55 71 47 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAL1-WHI5-WT-GFP</italic>
###xml 240 244 232 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MSN5</italic>
###xml 252 256 244 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAL1</italic>
###xml 316 332 308 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAL1-WHI5-WT-GFP</italic>
###xml 336 355 328 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAL1-WHI5-12Ala-GFP</italic>
###xml 495 504 487 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">msn5&#916;</italic>
###xml 509 518 497 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">swi6&#916;</italic>
(A) msn5Delta cells, or (B) swi6Delta cells containing GAL1-WHI5-WT-GFP CEN plasmid were grown in galactose media and photographed for Whi5-GFP fluorescence in unbudded and budded cells. Representative cells are shown. (C) Cells expressing MSN5 from a GAL1 promoter integrated at the endogenous locus contain either GAL1-WHI5-WT-GFP or GAL1-WHI5-12Ala-GFP CEN plasmids. Cells were grown and photographed as above. (D) Anti-Myc western blot of immunopurified Whi5-WT-13xMyc from wild type cells, msn5Delta, or swi6Delta cells untreated or treated with lambda phosphatase. Arrows indicate presence of three different migrating species.
###end p 51
###begin title 52
Whi5 C-terminal CDK sites affect cell size
###end title 52
###begin p 53
###xml 92 99 92 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WHI5-WT</italic>
###xml 143 147 143 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WHI5</italic>
###xml 177 185 177 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SWI6-SA4</italic>
###xml 243 247 243 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAL1</italic>
###xml 264 270 264 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004300-g004">Fig. 4</xref>
###xml 439 446 439 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004300-g007">Fig. 7A</xref>
###xml 573 590 573 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WHI5-12A SWI6-SA4</italic>
###xml 633 648 633 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WHI5-WT SWI6-WT</italic>
###xml 656 663 656 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004300-g007">Fig. 7B</xref>
###xml 719 738 719 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WHI5-12Ala SWI6-SA4</italic>
###xml 771 778 771 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004300-g007">Fig. 7C</xref>
###xml 1056 1063 1056 1063 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WHI5-WT</italic>
###xml 1068 1076 1068 1076 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SWI6-SA4</italic>
###xml 1092 1110 1092 1110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WHI5-12Ala SWI6-WT</italic>
###xml 1149 1164 1149 1164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WHI5-WT SWI6-WT</italic>
###xml 1383 1384 1383 1384 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 1647 1654 1647 1654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004300-g007">Fig. 7C</xref>
###xml 1723 1724 1723 1724 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
To determine if the four C-terminal CDK sites of Whi5 affect normal cell cycle progression, WHI5-WT and mutant alleles were expressed from the WHI5 promoter in combination with SWI6-SA4. In contrast to cells overexpressing Whi5-12Ala from the GAL1 promoter (as in Fig. 4), cells expressing Whi5-12Ala and Swi6-SA4 from their own promoters at physiologic levels are viable and grow at rates similar to cells expressing Whi5-WT and Swi6-WT (Fig. 7A) and have normal cell cycle profiles (data not shown). When cells were synchronized in G1 with mating pheromone and released, WHI5-12A SWI6-SA4 cells budded at the same time and rate as WHI5-WT SWI6-WT cells (Fig. 7B). Although the cells displayed no overt growth defect, WHI5-12Ala SWI6-SA4 co-expressing cells were large (Fig. 7C). The mean cell volume (fL) of cells co-expressing Whi5-12Ala and Swi6-SA4 was 67.6 fL, 40% larger than cells expressing wild type WHI5 and SWI6 with a mean of 48.2 fL, indicating that phosphorylation of either Swi6 or Whi5 is necessary for regulation of cell size. Cells with WHI5-WT and SWI6-SA4, or cells with WHI5-12Ala SWI6-WT, were similar in size distribution to WHI5-WT SWI6-WT cells, demonstrating that the effect on cell size is not observed in cells with either mutant alone. We also analyzed the cell size distribution of Whi5 CDK mutants. When expressed with Swi6-WT, Whi5-4Ala and Whi5-8Ala1 cells were similar in size to Whi5-WT and Whi5-12Ala (data not shown). In contrast, cells expressing Swi6-SA4 with Whi5-4Ala (CDK sites 8, 9, 10, 12 Ala) were larger in size, with a mean size of 62.0 fL, with a similar distribution as Swi6-SA4 Whi5-12Ala cells (Fig. 7C). Conversely, the size distribution of Swi6-SA4 cells with Whi5-8Ala1 (CDK sites 8, 9, 10, 12 WT), with a mean size of 54.6, was similar to that of cells containing both wild type alleles. These results demonstrate that in combination with Swi6-SA4, phosphorylation of Whi5 C-terminal CDK sites (8, 9, 10, and 12) is essential for maintenance of cell size.
###end p 53
###begin title 54
Whi5 C-terminal CDK sites are required for maintenance of cell size.
###end title 54
###begin p 55
###xml 38 56 38 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">swi6&#916;whi5&#916;</italic>
###xml 137 141 129 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WHI5</italic>
###xml 403 412 395 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">whi5&#916;</italic>
###xml 424 433 412 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">swi6&#916;</italic>
###xml 452 470 436 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">swi6&#916;whi5&#916;</italic>
###xml 574 578 550 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WHI5</italic>
(A) Growth rates measured by OD600 of swi6Deltawhi5Delta cells expressing Swi6-WT or Swi6-SA4, and Whi5-WT or Whi5-12Ala from the 545 bp WHI5 promoter fragment on CEN plasmids. (B) Budding index of the same strains as in A. Cells were synchronized with alpha factor and released into fresh media. Budded cells were counted every 10 minutes. (C) Cell size distribution analysis wild type cells (BY4741), whi5Delta cells, and swi6Delta cells compared to swi6Deltawhi5Delta cells expressing Swi6-WT or Swi6-SA4, and Whi5-WT, Whi5-12Ala, Whi5-4Ala, or Whi5-8Ala from the 545 bp WHI5 promoter fragment on CEN plasmids.
###end p 55
###begin title 56
Discussion
###end title 56
###begin title 57
Whi5 CDK and non-CDK phosphorylation
###end title 57
###begin p 58
###xml 110 113 110 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Costanzo1">[9]</xref>
###xml 115 119 115 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-deBruin1">[10]</xref>
###xml 425 432 425 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 825 829 825 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Ptacek1">[39]</xref>
###xml 898 902 898 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Glover1">[40]</xref>
###xml 996 1005 996 1001 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">whi5&#916;</italic>
Whi5 is a negative regulator of G1 cell cycle progression that is inactivated by CDK phosphorylation at Start [9], [10]. Whi5 contains 12 putative CDK phosphorylation sites. However, it has remained unclear if specific CDK phosphorylations sites on Whi5 are utilized for inactivation or if a critical phosphorylation threshold of randomly distributed CDK sites induces inactivation. Here we found that Whi5 is phosphorylated in vivo on 10 CDK sites and 6 novel, non-CDK sites. We also observed that Whi5 is found hypo-phosphorylated at all stages of the cell cycle, including early G1. We did not observe un-phosphorylated Whi5, even in mating pheromone arrested cells. Five out of 6 of the non-CDK sites are followed by acidic residues and conform to the consensus sequences for casein kinase I or casein kinase II (CKA1/2) [39], which is known to target transcription factors and RNA polymerases [40]. We also found that hypo-phosphorylation is not required for the repressive function Whi5 as whi5Delta cells expressing Whi5-18Ala (all CDK and non-CDK sites mutated to alanine) are normal in cell size and overexpression of Whi5-18Ala causes lethality in cln3Delta cells. Further experiments are needed to explore the biological function of Whi5 non-CDK phosphorylation and identify the kinase(s) responsible.
###end p 58
###begin p 59
###xml 237 241 237 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WHI5</italic>
###xml 501 505 501 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MET3</italic>
###xml 654 658 642 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-deBruin1">[10]</xref>
In addition to showing that Whi5 hypo-phosphorylation is not essential for inhibitory function, this analysis shows that phosphorylation is neither essential for Whi5 inactivation nor passage through Start. Whi5-12Ala expressed from the WHI5 promoter fails to effect cell size distribution, indicating that the timing of cell cycle entry is not significantly affected by the phosphorylation site mutations. Our results differ from those of de Bruin et al, who report that Whi5-7Ala expressed from the MET3 promoter caused a measurable defect in cell cycle progression, with cells inducing maximum SBF transcription at a approximately10% larger cell size [10]. The difference in results may be due to strain background differences or the use of the heterologous promoter. Nevertheless, the reported effect of Whi5-7Ala was not as significant as would be predicted if Whi5 phosphorylation was essential for SBF activation.
###end p 59
###begin title 60
Redundancy of Whi5 and Swi6 Phosphorylation
###end title 60
###begin p 61
###xml 445 453 445 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SWI6-SA4</italic>
###xml 619 623 619 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Sidorova1">[16]</xref>
###xml 722 737 722 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAL1-WHI5-12Ala</italic>
###xml 815 818 815 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Costanzo1">[9]</xref>
###xml 1530 1534 1530 1534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Nash1">[41]</xref>
In contrast to the finding that Whi5 phosphorylation is not essential for cell size regulation at physiologic expression levels, phosphorylation of Whi5 and Swi6 becomes essential when Whi5 is overexpressed, as phosphomutants of these proteins synergize to cause lethality. Swi6 has 5 putative CDK phosphorylation sites; four of the five are in the N-terminal region, while the fifth CDK site is a part of the ankyrin repeat domain of Swi6. The SWI6-SA4 mutant created by Sidorova, et al., that contains mutations of the four N-terminal CDK sites, does not affect periodic transcription of SBF targets (data not shown) [16]. While Swi6-SA4 alone does not have a significant cell cycle phenotype, Swi6-SA4 cells expressing GAL1-WHI5-12Ala are inviable and arrest as large, elongated, unbudded cells (data not shown) [9]. We exploited this phenotype in a mutational analysis of Whi5 CDK sites to identify four C-terminal CDK sites of Whi5, sites 8, 9, 10, and 12, that are necessary and sufficient to prevent lethality when Whi5 is overexpressed in combination with Swi6-SA4. Importantly, Whi5 retaining four or more N-terminal CDK sites intact was not sufficient to prevent lethality. This demonstrates that specific CDK sites of Whi5 are required for inactivation, rather than simply a threshold number. Consequently, we can exclude a model similar to that adopted for proteins such as Sic1 that require a threshold number of CDK phosphorylations to induce inactivation without a requirement for specific sites of phosphorylation [41]. These four phosphorylated residues of Whi5 may function to induce a conformational change or otherwise influence the interaction between Whi5 and SBF components. We conclude that phosphorylation of Whi5 and Swi6 is redundant, and that phosphorylation facilitates Whi5 inactivation.
###end p 61
###begin p 62
###xml 106 110 106 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Sidorova1">[16]</xref>
###xml 112 116 112 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Geymonat1">[18]</xref>
###xml 357 361 357 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Sidorova1">[16]</xref>
###xml 515 518 515 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Costanzo1">[9]</xref>
CDK phosphorylation of Swi6 participates in the inactivation of Swi6 by inducing cytoplasmic localization [16], [18]. Swi6 Serine-160 is adjacent to a nuclear localization sequence and inhibits nuclear import once phosphorylated. When Ser-160 is mutated to alanine, as it is in the Swi6-SA4 mutant, this results in constitutive nuclear localization of Swi6 [16]. Whi5 is also exported from the nucleus upon CDK phosphorylation and a C-terminal phosphorylation mutant of Whi5 (sites 7-12 alanine) is largely nuclear [9]. Analysis of Whi5-GFP localization shows four C-terminal sites (8, 9, 10, and 12) are involved in nuclear export, as Whi5-4A was unable to be completely exported to the cytoplasm in budded cells, but are not sufficient to control localization, as Whi5-8Ala (8, 9, 10, and 12 wild type) remained nuclear in two thirds of budded cells. This suggests that the four CDK sites implicated in Whi5 inactivation differ from the CDK sites required to induce Whi5 nuclear export, and highlights a function for CDK sites 7 and 11 in Whi5 export. These data also indicate that Whi5 dissociation from SBF and its subsequent export to the cytoplasm are distinct steps requiring phosphorylation of different CDK sites.
###end p 62
###begin p 63
###xml 45 53 45 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SWI6-SA4</italic>
###xml 735 753 735 753 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WHI5-4Ala SWI6-SA4</italic>
###xml 787 806 787 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WHI5-12Ala SWI6-SA4</italic>
###xml 835 836 835 836 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 826 836 826 836 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WHI5-8Ala<sup>1</sup></italic>
###xml 906 913 906 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WHI5-WT</italic>
###xml 933 941 933 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SWI6-SA4</italic>
###xml 1705 1709 1705 1709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-DiComo1">[42]</xref>
###xml 1711 1715 1711 1715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Wijnen2">[43]</xref>
Despite the dramatic cell cycle phenotype of SWI6-SA4 cells when Whi5-12Ala is overexpressed, CDK phosphorylation of Whi5 and Swi6 is not essential for viability when Whi5 is expressed at physiologic levels. Cells expressing both Swi6-SA4 and Whi5-12Ala under control of their own promoters are completely viable, grow at normal rates, and enter the cell cycle after mating pheromone induced G1 arrest with normal kinetics. Their only apparent defect is a large cell size, suggesting that cells are delayed in passing Start when Whi5 and Swi6 cannot be phosphorylated. The four Whi5 CDK sites (8, 9, 10, and 12) identified in the overexpression assay with Swi6-SA4 are also necessary and sufficient to promote cell size regulation, as WHI5-4Ala SWI6-SA4 cells were equivalent in size to WHI5-12Ala SWI6-SA4 cells. Conversely, WHI5-8Ala1 (CDK sites 8, 9, 10, and 12 wild type) cells were similar in size to WHI5-WT when combined with SWI6-SA4. The effect of these mutants on cell size indicates that the four specific CDK sites are important for the timing of Whi5 inactivation, even at physiologic expression levels. However, these data also imply that Whi5 and Swi6 are not essential targets of Cln-Cdc28 for cell viability when expressed at physiologic levels, and phosphorylation of Swi6 or the four sites of Whi5 is only required for proper coordination of cell size with cell cycle entry. In the absence of available CDK sites on Whi5 or Swi6, cells must use a mechanism other than CDK phosphorylation to activate SBF transcription. It is possible that the cell cycle activator Bck2 plays a role under these conditions, given its ability to activate SBF transcription independently of Cdc28 activity [42], [43].
###end p 63
###begin title 64
Parallels between Whi5 and Rb
###end title 64
###begin p 65
###xml 403 407 403 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Ezhevsky1">[24]</xref>
###xml 792 796 792 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Lees1">[44]</xref>
###xml 798 802 798 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Mittnacht1">[45]</xref>
###xml 1099 1103 1099 1103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004300-Ezhevsky2">[28]</xref>
###xml 45 50 <span type="species:ncbi:4932">yeast</span>
###xml 1318 1323 <span type="species:ncbi:4932">yeast</span>
The pathway of transcriptional activation in yeast is functionally similar to the mechanism of cell cycle entry in mammalian cells. Whi5 is a functional analog of the Retinoblastoma tumor suppressor protein that also represses transcription in early G1. Previous studies from our laboratory show that Rb bound to E2F transcription factors in early G1 is hypo-phosphorylated on CDK phosphorylation sites [24]. Whi5 is similarly hypo-phosphorylated in early G1, but hypo-phosphorylation is not necessary for its repressive function. Further experiments are needed to determine the requirement for Rb hypo-phosphorylation in repression of E2F promoters. Additionally, phosphopeptide maps of hyper-phosphorylated Rb during late G1 are nearly identical to hypo-phosphorylated Rb found in early G1 [44], [45], indicating that individual CDK sites are targeted equally in Rb phosphorylation and suggesting specific sites do not have a significant function. This suggests a model of Rb regulation where inactivation by hyper-phosphorylation is achieved by phosphorylation of a threshold number of CDK sites [28]. In contrast to that model for Rb, we identified specific CDK sites that function in Whi5 inactivation and regulation of cell size. Because the regulatory pathways of cell cycle entry are largely conserved between yeast and mammalian cells, the mechanism of regulation by specific phosphorylation observed for Whi5 suggests further investigation of Rb phosphorylation in mammalian systems is warranted.
###end p 65
###begin p 66
We thank Mike Tyers (University of Toronto), Linda Breeden (Fred Hutchinson Cancer Research Center), and Rainer Brachmann (UC Irvine) for plasmid constructs.
###end p 66
###begin title 67
References
###end title 67
###begin article-title 68
###xml 32 37 <span type="species:ncbi:4932">yeast</span>
Start-specific transcription in yeast.
###end article-title 68
###begin article-title 69
A restriction point for control of normal animal cell proliferation.
###end article-title 69
###begin article-title 70
###xml 49 54 <span type="species:ncbi:4932">yeast</span>
###xml 55 79 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Coordination of growth with cell division in the yeast Saccharomyces cerevisiae.
###end article-title 70
###begin article-title 71
###xml 90 95 <span type="species:ncbi:4932">yeast</span>
###xml 96 120 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Regulation of Cdc28 cyclin-dependent protein kinase activity during the cell cycle of the yeast Saccharomyces cerevisiae.
###end article-title 71
###begin article-title 72
###xml 66 71 <span type="species:ncbi:4932">yeast</span>
###xml 72 96 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Comprehensive identification of cell cycle-regulated genes of the yeast Saccharomyces cerevisiae by microarray hybridization.
###end article-title 72
###begin article-title 73
A genome-wide transcriptional analysis of the mitotic cell cycle.
###end article-title 73
###begin article-title 74
###xml 38 43 <span type="species:ncbi:4932">yeast</span>
Cell cycle-dependent transcription in yeast: promoters, transcription factors, and transcriptomes.
###end article-title 74
###begin article-title 75
A role for the transcription factors Mbp1 and Swi4 in progression from G1 to S phase.
###end article-title 75
###begin article-title 76
###xml 69 74 <span type="species:ncbi:4932">yeast</span>
CDK activity antagonizes Whi5, an inhibitor of G1/S transcription in yeast.
###end article-title 76
###begin article-title 77
Cln3 activates G1-specific transcription via phosphorylation of the SBF bound repressor Whi5.
###end article-title 77
###begin article-title 78
###xml 76 100 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Roles and regulation of Cln-Cdc28 kinases at the start of the cell cycle of Saccharomyces cerevisiae.
###end article-title 78
###begin article-title 79
###xml 18 42 18 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 18 42 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Comparison of the Saccharomyces cerevisiae G1 cyclins: Cln3 may be an upstream activator of Cln1, Cln2 and other cyclins.
###end article-title 79
###begin article-title 80
###xml 89 113 89 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 89 113 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
DAF1, a mutant gene affecting size control, pheromone arrest, and cell cycle kinetics of Saccharomyces cerevisiae.
###end article-title 80
###begin article-title 81
###xml 78 83 <span type="species:ncbi:4932">yeast</span>
Systematic identification of pathways that couple cell growth and division in yeast.
###end article-title 81
###begin article-title 82
The G(1) cyclin Cln3 promotes cell cycle entry via the transcription factor Swi6.
###end article-title 82
###begin article-title 83
Cell cycle-regulated phosphorylation of Swi6 controls its nuclear localization.
###end article-title 83
###begin article-title 84
###xml 46 51 <span type="species:ncbi:4932">yeast</span>
Switching transcription on and off during the yeast cell cycle: Cln/Cdc28 kinases activate bound transcription factor SBF (Swi4/Swi6) at start, whereas Clb/Cdc28 kinases displace it from the promoter in G2.
###end article-title 84
###begin article-title 85
Clb6/Cdc28 and Cdc14 regulate phosphorylation status and cellular localization of Swi6.
###end article-title 85
###begin article-title 86
Constraining G1-specific transcription to late G1 phase: the MBF-associated corepressor Nrm1 acts via negative feedback.
###end article-title 86
###begin article-title 87
From G0 to S phase: a view of the roles played by the retinoblastoma (Rb) family members in the Rb-E2F pathway.
###end article-title 87
###begin article-title 88
The Rb/E2F pathway: expanding roles and emerging paradigms.
###end article-title 88
###begin article-title 89
Functions of the retinoblastoma protein.
###end article-title 89
###begin article-title 90
Regulation of G(1) cell-cycle progression by oncogenes and tumor suppressor genes.
###end article-title 90
###begin article-title 91
Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb.
###end article-title 91
###begin article-title 92
Differential regulation of retinoblastoma protein function by specific Cdk phosphorylation sites.
###end article-title 92
###begin article-title 93
The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2.
###end article-title 93
###begin article-title 94
Cumulative effect of phosphorylation of pRB on regulation of E2F activity.
###end article-title 94
###begin article-title 95
Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo.
###end article-title 95
###begin article-title 96
###xml 92 116 92 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 92 116 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Additional modules for versatile and economical PCR-based gene deletion and modification in Saccharomyces cerevisiae.
###end article-title 96
###begin article-title 97
###xml 39 63 39 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 39 63 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Designer deletion strains derived from Saccharomyces cerevisiae S288C: a useful set of strains and plasmids for PCR-mediated gene disruption and other applications.
###end article-title 97
###begin article-title 98
Dynamic changes in protein-protein interaction and protein phosphorylation probed with amine-reactive isotope tag.
###end article-title 98
###begin article-title 99
Grr1-dependent inactivation of Mth1 mediates glucose-induced dissociation of Rgt1 from HXT gene promoters.
###end article-title 99
###begin article-title 100
###xml 35 59 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Cln3-associated kinase activity in Saccharomyces cerevisiae is regulated by the mating factor pathway.
###end article-title 100
###begin article-title 101
Far1 and Fus3 link the mating pheromone signal transduction pathway to three G1-phase Cdc28 kinase complexes.
###end article-title 101
###begin article-title 102
Cell cycle activation of the Swi6p transcription factor is linked to nucleocytoplasmic shuttling.
###end article-title 102
###begin article-title 103
Calcineurin-dependent regulation of Crz1p nuclear export requires Msn5p and a conserved calcineurin docking site.
###end article-title 103
###begin article-title 104
###xml 90 114 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
The nuclear exportin Msn5 is required for nuclear export of the Mig1 glucose repressor of Saccharomyces cerevisiae.
###end article-title 104
###begin article-title 105
The receptor Msn5 exports the phosphorylated transcription factor Pho4 out of the nucleus.
###end article-title 105
###begin article-title 106
###xml 46 51 <span type="species:ncbi:4932">yeast</span>
Global analysis of protein phosphorylation in yeast.
###end article-title 106
###begin article-title 107
###xml 49 73 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
On the physiological role of casein kinase II in Saccharomyces cerevisiae.
###end article-title 107
###begin article-title 108
Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replication.
###end article-title 108
###begin article-title 109
Activation of CLN1 and CLN2 G1 cyclin gene expression by BCK2.
###end article-title 109
###begin article-title 110
###xml 81 105 81 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 81 105 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Genetic analysis of the shared role of CLN3 and BCK2 at the G(1)-S transition in Saccharomyces cerevisiae.
###end article-title 110
###begin article-title 111
###xml 66 71 <span type="species:ncbi:9606">human</span>
The retinoblastoma protein is phosphorylated on multiple sites by human cdc2.
###end article-title 111
###begin article-title 112
Distinct sub-populations of the retinoblastoma protein show a distinct pattern of phosphorylation.
###end article-title 112
###begin p 113
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 113
###begin p 114
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: M.V.W. was funded by the NIH Cancer Cell Biology Training grant (CA067754) and the NIH Basic Clinical Genetics Training grant (GM008666). This work was supported by the Howard Hughes Medical Institute (S.F.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 114

